{
  "docId": "019de076-ab6f-74fc-ae2c-88fa7eed31fd",
  "docSlug": "9e6f9592721adb102aeba3d640e068ca",
  "documentTitle": "Immix Biopharma | Investor Presentation Deck | 64 slides",
  "authorId": "immix-biopharma",
  "authorName": "Immix Biopharma",
  "documentKindSlug": "deck",
  "documentKindLabel": "Deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 63,
  "pageCount": 64,
  "prevPage": 62,
  "nextPage": 64,
  "slideType": "other",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a 3-pillar framework to categorize the platform's foundation, leading to specific product applications.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de076-ab6f-74fc-ae2c-88fa7eed31fd/63",
  "deckHref": "/decks/019de076-ab6f-74fc-ae2c-88fa7eed31fd",
  "deckJsonHref": "/decks/019de076-ab6f-74fc-ae2c-88fa7eed31fd.json",
  "deckAnchorHref": "/decks/019de076-ab6f-74fc-ae2c-88fa7eed31fd#slide-63",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.1,
        "x": 0.55,
        "y": 0.35
      },
      "kind": "image",
      "text": "Molecular structure diagrams for IMX-110, IMX-111, IMX-120",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10610671-20f6-4e5c-a5df-6294ad543d97",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.35,
        "x": 0.02,
        "y": 0.35
      },
      "kind": "list",
      "text": "System-Tissue Biology Model Development\nPurpose-Built Physical Biochemistry Engine\nPredictive Validation Framework",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47799f37-2345-4001-91fc-c4d3472fa88f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.3,
        "x": 0.68,
        "y": 0.33
      },
      "kind": "paragraph",
      "text": "IMX-110: negatively-charged Tissue-Specific Therapeutic™... 1,200% increase in apoptosis\nIMX-111: Tissue-Specific Biologic™... Colorectal Cancer (CRC)\nIMX-120: Tissue-Specific Biologic™... selectively silencing disease-causing inflammatory bowel immune cells.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e1a2351-5107-4f46-adda-3ac1b54870ab",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.4,
        "x": 0.02,
        "y": 0.04
      },
      "kind": "title",
      "text": "IMMiXBio™ SMARXT Tissue-Specific™ Platform",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "76bf7d71-6b89-4b4f-94ba-ea02d68b4bde",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.9,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "title",
      "text": "TME Normalization™ Technology – SMARXT Tissue-Specific Platform Oncology Application",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a867d0cc-9d74-460d-a7f0-ca74cfd93a1e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "3-pillar framework",
      "slug": null,
      "matchId": "31732010-9ad0-4568-84de-5cdbb6b02ebf",
      "evidence": "The slide explicitly labels the left column as '3 Pillars'.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 64,
      "from": 37,
      "beatId": "55323ebe-ee93-4119-be72-15ce337e4875",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Slides 37-64 discuss the market opportunity, clinical development plan, and upcoming catalysts",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}